These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Seizure suppression and neuroprotection in soman-exposed rats following delayed intramuscular treatment of adenosine A1 receptor agonist as an adjunct to standard medical treatment. Keith ZM, Munoz C, Acon-Chen C, Shih TM. Toxicol Appl Pharmacol; 2024 Jul; 488():116970. PubMed ID: 38777098 [Abstract] [Full Text] [Related]
3. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment. De Araujo Furtado M, Aroniadou-Anderjaska V, Figueiredo TH, Pidoplichko VI, Apland JP, Rossetti K, Braga MFM. J Pharmacol Exp Ther; 2024 Jan 17; 388(2):432-450. PubMed ID: 37739807 [Abstract] [Full Text] [Related]
4. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication. Althaus AL, McCarren HS, Alqazzaz A, Jackson C, McDonough JH, Smith CD, Hoffman E, Hammond RS, Robichaud AJ, Doherty JJ. Epilepsy Behav; 2017 Mar 17; 68():22-30. PubMed ID: 28109985 [Abstract] [Full Text] [Related]
5. Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents. Wu X, Kuruba R, Reddy DS. J Pharmacol Exp Ther; 2018 Nov 17; 367(2):302-321. PubMed ID: 30115757 [Abstract] [Full Text] [Related]
6. Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus. Barker BS, Spampanato J, McCarren HS, Smolik M, Jackson CE, Hornung EN, Yeung DT, Dudek FE, McDonough JH. Neuroscience; 2020 Jan 15; 425():280-300. PubMed ID: 31783100 [Abstract] [Full Text] [Related]
15. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats. Lumley LA, Marrero-Rosado B, Rossetti F, Schultz CR, Stone MF, Niquet J, Wasterlain CG. Epilepsia Open; 2021 Dec 15; 6(4):757-769. PubMed ID: 34657398 [Abstract] [Full Text] [Related]
16. Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage. Singh T, Ramakrishnan S, Wu X, Reddy DS. J Pharmacol Exp Ther; 2024 Jan 17; 388(2):313-324. PubMed ID: 37770202 [Abstract] [Full Text] [Related]
17. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy. Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Braga MF. Neurobiol Dis; 2020 Jan 17; 133():104406. PubMed ID: 30798006 [Abstract] [Full Text] [Related]
18. Rational polytherapy in the treatment of cholinergic seizures. Niquet J, Lumley L, Baldwin R, Rossetti F, Suchomelova L, Naylor D, Estrada IBF, Schultz M, Furtado MA, Wasterlain CG. Neurobiol Dis; 2020 Jan 17; 133():104537. PubMed ID: 31454548 [Abstract] [Full Text] [Related]
19. A novel genetically modified mouse seizure model for evaluating anticonvulsive and neuroprotective efficacy of an A1 adenosine receptor agonist following soman intoxication. Shih TM. Toxicol Appl Pharmacol; 2023 Apr 01; 464():116437. PubMed ID: 36849019 [Abstract] [Full Text] [Related]